TNFSF10 and lung carcinoma: We built upon these findings by re-treating two known resistant cell lines of diverse cancer types of cervical and lung cancer, HeLa C9, and NCIH460, with TRAIL 10 d after an initial treatment, followed by mass cytometry analysis (Fig 2A, top).